1. Home
  2. News
  3. Hunan Nucien Pharmaceutical Co. Ltd.
  4. Announcement on Proposed Cancellation of Subsidiary
More Hunan Nucien Pharmaceutical Co. Ltd. news
Hunan Nucien Pharmaceutical Co. Ltd.SSE: 688189

Announcement on Proposed Cancellation of Subsidiary

Apr 30, 2025 · Issued by Hunan Nucien Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 30, 2025 · 3 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-proposed-cancellation-of-subsidiary

Hunan Nucien Pharmaceutical Co. Ltd. on 6ix

Later from Hunan Nucien Pharmaceutical

  • Announcement on Shareholding of Top 10 Shareholders and Top 10 Shareholders without Sales Limit Concerning Shares RepurchaseMay 8, 2025
  • Announcement on Using Extra Raised Funds to Permanently Supplement Current CapitalMay 24, 2025
  • Announcement on Initially Repurchasing the Company's Shares through Call AuctionMay 31, 2025
  • Announcement on Resolution of the 2024 Annual General MeetingJun 14, 2025
  • Announcement on Abnormal Fluctuations in Stock TradingJul 31, 2025
All Hunan Nucien Pharmaceutical news releases↗

Follow Hunan Nucien Pharmaceutical into a list and get an email when it puts out news.

Follow Hunan Nucien Pharmaceutical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer